WA
IART icon

WPG Advisers’s Integra LifeSciences IART Stock Holding History

WPG Advisers’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$467 Hold
26
– – ﹤0.01% 1446
2026
Q1 		$245 Sell
26
-24
-48% -$264 ﹤0.01% 1421
2025
Q4 		$621 Hold
50
– – ﹤0.01% 1357
2025
Q3 		$717 Buy
50
+1
+2% +$14 ﹤0.01% 1320
2025
Q2 		$601 Hold
49
– – ﹤0.01% 1333
2025
Q1 		$1.08K Buy
49
+25
+104% +$588 ﹤0.01% 1236
2024
Q4 		$544 Buy
+24
New +$524 ﹤0.01% 1331

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

WPG Advisers's IART Position: Q2 2026 in Review

WPG Advisers held its Integra LifeSciences (IART) position steady in Q2 2026 at 26 shares worth $467. The position accounts for ﹤0.01% of the portfolio, ranked #1446.

WPG Advisers first reported a position in IART in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.08K in Q1 2025. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • WPG Advisers held 26 shares of Integra LifeSciences worth $467 as of Q2 2026.
  • WPG Advisers left its Integra LifeSciences share count unchanged in Q2 2026.
  • Integra LifeSciences made up ﹤0.01% of WPG Advisers's portfolio in Q2 2026, its #1446 holding.
  • WPG Advisers first reported a position in Integra LifeSciences in Q4 2024 and has held it in 7 quarters since.
  • WPG Advisers's Integra LifeSciences position peaked at $1.08K in Q1 2025.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.